RecruitingNCT07192991

Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America

Sponsor

Latin American Cooperative Oncology Group

Enrollment

200 participants

Start Date

Dec 16, 2025

Study Type

OBSERVATIONAL

Conditions

Neuroendocrine Carcinomas Lung Neuroendocrine Carcinoma

Summary

This observational, retrospective study aims to understand the treatment patterns and outcomes of patients with pulmonary and extra-pulmonary neuroendocrine carcinomas (NEC) in Latin America (Brazil, Mexico, Argentina, and Peru). The research will collect data from medical records to analyze factors like patient demographics, diagnosis methods, tumor characteristics, treatment approaches, and disease progression. The study is non-interventional, meaning patient care will follow standard clinical practice, with data gathered via an electronic system.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Observational study for people with lung neuroendocrine carcinoma and neuroendocrine carcinomas. The study is currently recruiting participants at 19 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservational study

This is an observational study; patients will not be exposed to clinical interventions different from those belonging to the standard of care.

Locations(19)

Hospital Británico de Buenos Aires

Buenos Aires, Buenos Aires, Argentina

Hospital de Gastroenterología Carlos Bonorino Udaondo

Buenos Aires, Buenos Aires, Argentina

Instituto Alexander Fleming

Buenos Aires, Buenos Aires, Argentina

Hospital Evangélico de Cachoeiro de Itapemirim - Centro de Pesquisas Clínicas em Oncologia (CPCO)

Cachoeiro de Itapemirim, Espírito Santo, Brazil

Clínica Prognóstica - Centro de Pesquisa Clínica Onconeo

Campo Grande, Mato Grosso do Sul, Brazil

Oncocentro de Minas Gerais (Oncoclínicas)

Belo Horizonte, Minas Gerais, Brazil

IOP Pesquisa - Instituto de Oncologia do Paraná

Curitiba, Paraná, Brazil

HCL - Hospital do Câncer de Londrina

Londrina, Paraná, Brazil

INCA - Instituto Nacional de Câncer

Rio de Janeiro, Rio de Janeiro, Brazil

HUOL - Hospital Universitário Onofre Lopes da UFRN

Natal, Rio Grande do Norte, Brazil

Liga Norte Riograndense Contra o Câncer

Natal, Rio Grande do Norte, Brazil

HMV - Hospital Moinhos de Vento

Porto Alegre, Rio Grande do Sul, Brazil

Futtura Oncologia - Hub de Pesquisa Clínica

Porto Alegre, Rio Grande do Sul, Brazil

ANIMI - Unidade de Tratamento Oncológico

Lages, Santa Catarina, Brazil

A.C. Camargo Cancer Center

São Paulo, São Paulo, Brazil

HIAE - Hospital Israelita Albert Einstein

São Paulo, São Paulo, Brazil

Centro Oncológico Internacional (COI)

Mexico City, Mexico City, Mexico

INCan - Instituto Nacional de Cancerología

Mexico City, Mexico City, Mexico

Oncosalud AUNA

Lima, Lima Province, Peru

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07192991

Related Trials

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

NCT0717458313 locations

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

NCT060415161 location